Screener
SI-BONE, Inc. SIBN Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by SI-BONE, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001459839-26-000056
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 6,025 | 6,663 |
| Depreciation and amortization | 1,617 | 1,278 |
| Accounts receivable credit losses | 90 | 91 |
| Amortization of discount and premium on marketable securities | (564) | (916) |
| Inventory reserve | 388 | 394 |
| Amortization of debt issuance costs | 29 | 29 |
| Loss on disposal of property and equipment | 332 | 287 |
Item 1. Financial Statements
FAQ
- What is SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal)?
- SI-BONE, Inc. (SIBN) reported accounts receivable, credit loss expense (reversal) of $90K in Q1 2026.
- How has SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
- SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) decreased by 1.1% year-over-year, from $91K to $90K.
- What is the long-term trend for SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal) has grown at a 152.6% compound annual growth rate (CAGR), from $14K to $570K.
Ask your AI about SI-BONE, Inc.'s accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude